앨버타 보건 서비스
Edmonton Metropolitan Region은 앨버타 보건 서비스(AHS) 본사로, 건강 관련 기업이 앨버타에서 사업을 시작하기 위해 찾는 전략적인 위치입니다. AHS는 캐나다 최초이자 최대의 지방 통합 보건 시스템으로, 400만 명 이상의 앨버타 주민에게 보건 서비스를 제공합니다. 연간 운영비용은 140억 달러를 초과합니다.
자연 제어 향상을 위한 생체 공학 신체(BLINC) 랩에 연구원과 임상의들이 모여 로봇과 기계 학습을 통해 인공 기관 관리를 발전시켰습니다. 주요 프로젝트로는 맞춤형 인공 기관 원형 제작, 인간의 움직임을 모방한 인공 기관 근전성 향상, 산업용 평가 도구 개발, 절단 등으로 상실된 인간의 능력을 회복하는 데 도움이 되는 기계 학습 활용 등이 있습니다.
Read More
New rapid COVID-19 test taking off at EIA
9월 24, 2020
GLC, Edmonton company, testing new technology exclusively at airport In partnership with GLC Medical (GLCM) Inc., a subsidiary of Graphene Leaders Canada (GLC) Inc., an Edmonton-based company, EIA will host clinical trials of this new technology that has the potential to have global implications for COVID-19 testing.
Read More
U of A researchers develop tool to help build better prosthetic limbs
8월 27, 2020
“There are prosthetic devices becoming available that are almost indistinguishable from real limbs, but the real problem is, if you think about how many different ways you can move your hand, each one of those would need a separate channel of information,” said Craig Chapman, a U of A movement neuroscientist in the Faculty of Kinesiology, Sport, and Recreation
Read More
Edmonton Global Webinar – Pharmaceutical Innovation and Production Opportunities in the Edmonton Metropolitan Region
7월 15, 2020
On July 21, 2020 at 8:00h(MDT) / 16:00 (CEDT) Edmonton Global will be hosting a webinar on the unique opportunities that exist for scalable pharmaceutical innovation and production in the Edmonton region.
Read More
U of A researcher to test whether COVID-19 antibodies provide long-term immunity
6월 29, 2020
Study among 13 U of A projects receiving $11.3 million in federal funding for rapid research response to pandemic.
Read More
Alberta built an artificial intelligence powerhouse. What’s next?
6월 26, 2020
Just off Highway 60, a short jaunt south of Devon, sits one of the most celebrated pieces of industrial equipment in the country. The collection of steel lattices has a name: Leduc #1, the derrick that struck oil south of Edmonton more than 70 years ago.
Read More
Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials
6월 25, 2020
Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform, today announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA vaccine (Covigenix) from its prototyping program launched at the onset of the global COVID-19 pandemic.
Read More
Questions? Get in touch
info@edmontonglobal.ca : 1-800-264-4952
info@edmontonglobal.ca : 1-800-264-4952
Suite 100 - 10020 100 St.NW -T5J 0N5 Edmonton, AB
© Edmonton Global. All rights reserved
